Biotech Innovator & Healthcare Visionary

C. Palani Palaniappan, Ph.D.

Founder & CEO, Aridica Corporation

"Democratizing healthcare through innovation"

C. Palani Palaniappan, Ph.D.
Denver / Boulder, Colorado

From a Village Without Electricity to CEO

Raised in a rural Indian village without electricity or running water, Palani's journey from humble beginnings to the helm of biotech innovation is a testament to the transformative power of science and determination.

His father, a dedicated teacher, passed away from brain cancer during Palani's doctoral studies — a profoundly personal loss that ignited a lifelong mission to make healthcare accessible to everyone, everywhere.

"My work reflects a commitment to advancing life sciences while addressing critical healthcare needs — ensuring that transformative therapies reach not just the privileged few, but all of humanity."

With over three decades in biotechnology — from mapping the human genome at GE Healthcare to leading innovation at Terumo BCT and winning Edison Awards at QuidelOrtho — Palani now channels his expertise into Aridica, where he's building technology to democratize immune cell therapy worldwide.

Leukemia & Lymphoma Society fundraiser
Mentor at Thop E-Cell, empowering underprivileged students in India

A Legacy of Innovation

30+ years driving breakthrough innovation across life sciences and healthcare

1993 – 1998

Postdoctoral Research Fellow

University of Rochester School of Medicine

Conducted pioneering research on HIV-1 reverse transcriptase mechanisms, publishing extensively in PNAS, J. Biological Chemistry, and Nucleic Acids Research. Laid the groundwork for understanding viral drug resistance.

Late 1990s – Early 2000s

Head of Molecular Diagnostics

GE Healthcare / Amersham Biosciences

Led development of DNA polymerase enzymes that were instrumental in mapping the entire human genome for the first time — a landmark achievement in the history of science.

2000s – 2010s

VP of R&D, Cellular Analysis

Life Technologies

Directed research and development in cellular analysis technologies, advancing tools that empower scientists worldwide in their pursuit of biological discovery.

2010s – 2019

EVP, Innovation & Development

Terumo BCT

Led global Innovation & Development with responsibility for the PMO, New Technology Ventures, Quality, Regulatory Affairs, and Scientific & Clinical Affairs. Initiated the Capgemini partnership to build global innovation centers leveraging IoT and AI. Contributed to over $2B in career revenue delivery.

2019 – 2020

Chief Technology Officer

Epic Sciences

Advanced liquid biopsy and precision oncology technologies, driving innovation at the intersection of computational biology and clinical diagnostics.

2020 – 2023

Chief Innovation Officer

Ortho Clinical Diagnostics → QuidelOrtho

Spearheaded a culture of innovation across global operations. Won five Edison Awards, including Gold 2022 for a breakthrough COVID-19 antibody test. Championed environmentally sustainable diagnostics technologies and affordable solutions from hospital to home.

Nov 2023 – Present

Founder & CEO

Aridica Corporation

Building the future of immune cell therapy — a disruptive microfluidic platform that democratizes PBMC isolation, making it accessible, automated, and affordable for researchers and clinicians worldwide.

$0B+ Revenue Delivered
0 Edison Awards
0 + Publications
0 + Years in Biotech

Aridica Corporation

Aridica is transforming the landscape of oncology and autoimmune disorders by democratizing immune cell isolation — bringing PBMC separation from bench to bedside through a single-push, automated microfluidic platform.

Single-Push Simple

Novice-friendly automated PBMC isolation that eliminates the variability and expertise required by traditional Ficoll gradient methods.

Under 30 Minutes

From whole blood to high-quality PBMCs and plasma — reproducible results in a fraction of the time, deployable anywhere in the world.

Broad Applications

Drug discovery, diagnostics and biomarker monitoring, CAR-T cell therapy development, and CBRN emergency preparedness.

Leadership Team

CP
C. Palani Palaniappan, Ph.D. CEO & Founder
SG
Sergey Gershtein CTO (ex-Abbott i-STAT)
CR
Charlie Robertson COO / CFO

Advisory Board

Stan Lapidus — Founder, Cytyc & Exact Sciences Charlie Kim — Verily (Alphabet) Joydeep Goswami — Former Illumina CFO
OEDIT Colorado Grant — $238K
BioTools Innovator 2025
VANGUARD / BARDA Accelerator

Board Memberships

DIA

Board Member

Jul 2023 – Present

Drug Information Association — serving on the LIFT Series Steering Committee and as a judge for the Whale Tank pitch competition. Championing the 4 D's: Drugs, Devices, Diagnostics, and Digital.

InVivo Biosystems

Board Member → Chairman

Jul 2019 – Present

Shaping strategic direction for CRISPR gene editing applications. Overseeing governance and advancing customized gene-edited models in zebrafish and nematodes to accelerate drug discovery.

Terumo Global Blood Management

Board Member

During Terumo BCT tenure

Contributing to global blood management strategy and innovation, advancing technologies that impact millions of patients through safer, more efficient blood component processing.

Scientific Foundation

~25 peer-reviewed publications across leading scientific journals

PNAS J. Biological Chemistry Nucleic Acids Research J. Bacteriology Biochemistry
Ph.D. Research

Vitamin K2 Biosynthesis

Northern Illinois University, 1989–1993

Investigated the molecular mechanisms of menaquinone (Vitamin K2) biosynthesis in E. coli, elucidating the menD and menC gene pathways critical to understanding blood biology and human gut bacteria.

Postdoctoral Research

HIV Reverse Transcriptase

University of Rochester, 1993–1998

Published 10+ papers on HIV-1 reverse transcriptase mechanisms — RNase H cleavage, strand transfer, viral DNA synthesis control, and replication fidelity — advancing understanding of viral drug resistance.

Awards & Honors

5

Edison Awards

Including Gold 2022 for breakthrough COVID-19 antibody test at Ortho Clinical Diagnostics / QuidelOrtho (2020–2022)

Mayor's Inspirational Leadership

City of Lakewood, Colorado — 2017

Recognized for outstanding leadership in healthcare innovation during tenure at Terumo BCT

BioTools Innovator 2025

Cohort Selection

Aridica selected from 400+ applicants for this prestigious life sciences tools accelerator program

VANGUARD Accelerator

BARDA Initiative

Selected for medical countermeasures development, advancing CBRN emergency preparedness capabilities

The 4 D's of Healthcare Innovation

A framework for patient-centric innovation that spans the full healthcare ecosystem

Drugs

From small molecules to living cell therapies — accelerating the journey from discovery to patient, with a focus on democratizing access to immune cell treatments.

Devices

Building intuitive, automated medical devices that remove complexity — from Terumo BCT's blood management systems to Aridica's microfluidic platform.

Diagnostics

Making diagnostics affordable and accessible from hospital to home — exemplified by Edison Award-winning innovations at QuidelOrtho and precision oncology at Epic Sciences.

Digital

Leveraging IoT, AI, and data to connect medical devices, enable decentralized clinical trials, and bring real-time insights to the point of care.

Let's Connect

Open to board opportunities, speaking engagements, partnerships, and conversations about democratizing healthcare.

LinkedIn Email
Denver / Boulder, CO